Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice

This research paper discuss Type 2 diabetes and how NAD+ biosynthesis is crtical to the process as well as supplementation outcomes.